Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA.
Iannone F, Favalli EG, Caporali R, D'Angelo S, Cantatore FP, Sarzi-Puttini P, Foti R, Conti F, Carletto A, Gremese E, Cauli A, Ramonda R, Palermo A, Epis O, Priora M, Bergossi F, Frediani B, Salaffi F, Lopalco G, Cacciapaglia F, Marchesoni A, Biggioggiero M, Bugatti S, Balduzzi S, Carriero A, Corrado A, Bongiovanni S, Benenati A, Miranda F, Fracassi E, Perra D, Ferraccioli G, Lapadula G. Iannone F, et al. Among authors: carriero a. Joint Bone Spine. 2021 Jan;88(1):105062. doi: 10.1016/j.jbspin.2020.07.011. Epub 2020 Aug 2. Joint Bone Spine. 2021. PMID: 32755721
Effectiveness and safety of secukinumab in 608 patients with psoriatic arthritis in real life: a 24-month prospective, multicentre study.
Ramonda R, Lorenzin M, Carriero A, Chimenti MS, Scarpa R, Marchesoni A, Lubrano di Scorpaniello E, Salvarani C, Cauli A, Semeraro A, Santo L, Ortolan A, Doria A, Fracassi E, Virelli G, Masia M, Fanizzi R, Visalli E, Amato G, Carletto A, Foti R; on behalf Spondyloartritis and Psoriatic Arthritis SIR Study Group “Antonio Spadaro”. Ramonda R, et al. Among authors: carriero a. RMD Open. 2021 Feb;7(1):e001519. doi: 10.1136/rmdopen-2020-001519. RMD Open. 2021. PMID: 33593933 Free PMC article.
Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study.
Ramonda R, Lorenzin M, Sole Chimenti M, D'Angelo S, Marchesoni A, Salvarani C, Lubrano E, Costa L, Dal Bosco Y, Fracassi E, Ortolan A, Ferraioli M, Carriero A, Visalli E, Bixio R, Desiati F, Bergamini A, Pedrollo E, Doria A, Foti R, Carletto A. Ramonda R, et al. Among authors: carriero a. Ther Adv Musculoskelet Dis. 2022 Apr 29;14:1759720X221090310. doi: 10.1177/1759720X221090310. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 35510168 Free PMC article.
Safety of treatment options for spondyloarthritis: a narrative review.
D'Angelo S, Carriero A, Gilio M, Ursini F, Leccese P, Palazzi C. D'Angelo S, et al. Among authors: carriero a. Expert Opin Drug Saf. 2018 May;17(5):475-486. doi: 10.1080/14740338.2018.1448785. Epub 2018 Mar 14. Expert Opin Drug Saf. 2018. PMID: 29505325 Review.
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis.
Atzeni F, Carriero A, Boccassini L, D'Angelo S. Atzeni F, et al. Among authors: carriero a. Immunotargets Ther. 2021 May 3;10:141-153. doi: 10.2147/ITT.S259126. eCollection 2021. Immunotargets Ther. 2021. PMID: 33977094 Free PMC article. Review.
Corticosteroid injection treatment for dactylitis in psoriatic arthritis.
Carriero A, Lubrano E, Picerno V, Padula AA, D'Angelo S. Carriero A, et al. Ther Adv Musculoskelet Dis. 2021 Aug 28;13:1759720X211041864. doi: 10.1177/1759720X211041864. eCollection 2021. Ther Adv Musculoskelet Dis. 2021. PMID: 34471429 Free PMC article. Review.
357 results